Sandrine M.G. van de Pol

Heidelberg University

Papers

1

Total Citations

2

H-Index

1

About

Sandrine M.G. van de Pol is a pioneering researcher at the intersection of medical robotics and interventional oncology, with a primary focus on advancing MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer. Her landmark work, the ROBiNSon study (2024), represents a proof-of-concept for robotic needle implantation under MRI guidance, demonstrating that a single intraprostatic target point can be accurately accessed using a custom robotic device. This contribution is foundational to the emerging field of MR-guided robotic brachytherapy, offering the potential for enhanced precision, reduced invasiveness, and improved patient outcomes. Although her most-cited paper currently has only 2 citations, its novelty and clinical relevance signal a growing impact. Van de Pol’s research bridges engineering and clinical practice, and her work is expected to influence future standards in image-guided interventions. As a researcher at the forefront of integrating robotics with real-time MR imaging, she is shaping the next generation of targeted cancer therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)—a proof-of-concept study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago